Latent Pneumocystis carinii Infection in Commercial Rat Colonies: Comparison of Inductive Immunosuppressants plus Histopathology, PCR, and Serology as Detection Methods
- 1 May 1999
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 37 (5) , 1441-1446
Abstract
Histopathologic evaluation combined with a period of immunosuppression has been the standard procedure for detection ofPneumocystis carinii in commercial rat colonies. Variation in induction regimens and in the sensitivity of detection methods may result in underreporting of the presence of P. cariniiin breeding colonies or delay its detection. In the present study, methylprednisolone and cyclophosphamide were evaluated for the ability to induce P. carinii infection in rats from an enzootically infected commercial barrier colony. The presence ofP. carinii was detected by histopathologic methods and by amplification of a targeted region of the P. carinii thymidylate synthase gene by PCR over the 8-week study period. Sera taken from rats prior to either induction regimen were evaluated for the presence of P. carinii-specific antibodies by the immunoblotting technique. Few significant differences in ability to induce organism burden or in histopathology were observed between the two immunosuppressive regimens. However, a dramatic loss of weight over the study period was observed in rats treated with methylprednisolone but not in rats treated with cyclophosphamide. Although histopathologic changes attributable toP. carinii did not appear before 2 weeks with either immunosuppressant, the presence of the organism in these animals was detected by immunoblotting and PCR. Cyst scores and the intensities of the histopathologic lesions increased during the study period, but the number of rats exhibiting evidence of P. cariniiinfection did not change after week 3. These results suggest that use of the PCR method on postmortem lung tissue of rats without prior induction regimens or identification of anti-P. carinii antibodies in antemortem serum samples is a sufficiently sensitive method for detection of the presence of a P. cariniicarrier state in rodent breeding colonies.Keywords
This publication has 25 references indexed in Scilit:
- V. Genetic heterogeneity of rat-derivedPneumocystisFEMS Immunology & Medical Microbiology, 1998
- II. The genome ofPneumocystis cariniiFEMS Immunology & Medical Microbiology, 1998
- Detection of Pneumocystis carinii in rats by polymerase chain reaction: comparison of lung tissue and bronchoalveolar lavage specimens.1996
- Characterization of multiple unique cDNAs encoding the major surface glycoprotein of rat-derivedPneumocystis cariniiParasitology Research, 1994
- DNA Amplification in Experimental Pneumocystosis: Characterization of Serum Pneumocystis carinii DNA and Potential P. carinii Carrier StatesThe Journal of Infectious Diseases, 1993
- Factors influencing Pneumocystis infection in the immunocompromised rat.1991
- Isolation and expression of the Pneumocystis carinii thymidylate synthase gene.Proceedings of the National Academy of Sciences, 1989
- HUMORAL IMMUNITY IN EXPERIMENTAL PNEUMOCYSTIS-CARINII INFECTION .1. SERUM AND BRONCHIAL LAVAGE FLUID ANTIBODY-RESPONSES IN RATS1981
- Comparison of Rat, Mouse, and Human Pneumocystis carinii by ImmunofluorescenceThe Journal of Infectious Diseases, 1980
- ANIMAL-MODEL OF HUMAN-DISEASE - PNEUMOCYSTIS PNEUMONIA1979